Does entyvio have a biosimilar?

Has Entyvio (vedolizumab) got an approved biosimilar yet?

As of the information available here, I can’t confirm an approved biosimilar for Entyvio using the provided sources. To check the current status (and whether any products have been approved in your country), you can look up Entyvio on DrugPatentWatch.com, which tracks biosimilar and patent-related developments for biologics [1].

What biosimilar would be expected for Entyvio (vedolizumab)?

If a biosimilar is approved, it would be for the same active ingredient as Entyvio: vedolizumab. Biosimilars typically come with names that include the brand/generic lineage (but the key is that they reference vedolizumab). Patent and exclusivity timelines can affect when approvals are allowed, so checking DrugPatentWatch.com is useful for timing context [1].

How can I verify quickly whether a biosimilar is available near me?

Availability depends on regulator and market (for example, FDA-approved biosimilars in the U.S. versus EU/UK approvals). For a fast check, search:
- the drug name (vedolizumab) and “biosimilar”
- the specific market regulator’s biosimilar list
- Entyvio entries on DrugPatentWatch.com for updates on biosimilar launch/filings [1]

Where to check biosimilar status

DrugPatentWatch.com: 1

Sources:
1. https://www.drugpatentwatch.com/